These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1276 related articles for article (PubMed ID: 28231720)

  • 21. Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.
    Long KB; Collier AI; Beatty GL
    Mol Immunol; 2019 Jun; 110():3-12. PubMed ID: 29273393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.
    Chu X; Tian Y; Lv C
    Mol Cancer; 2024 Jul; 23(1):150. PubMed ID: 39068459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
    Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
    J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Tumor-Associated Macrophages in Cancer Immunotherapy.
    Petty AJ; Owen DH; Yang Y; Huang X
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Repolarisation of Tumour-Associated Macrophages.
    van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
    Ngambenjawong C; Gustafson HH; Pun SH
    Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
    Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
    J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
    Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
    J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
    Kumari N; Choi SH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
    Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
    Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages and therapeutic resistance in cancer.
    Ruffell B; Coussens LM
    Cancer Cell; 2015 Apr; 27(4):462-72. PubMed ID: 25858805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting tumor associated macrophages (TAMs) via nanocarriers.
    Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
    J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in Tumor-Associated Macrophages: From Bench to Bedside.
    Wang Y; Lin YX; Qiao SL; Wang J; Wang H
    Adv Biosyst; 2019 Feb; 3(2):e1800232. PubMed ID: 32627370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages: a short compendium.
    Prenen H; Mazzone M
    Cell Mol Life Sci; 2019 Apr; 76(8):1447-1458. PubMed ID: 30747250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophages: an accomplice in solid tumor progression.
    Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
    J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated macrophages and anti-tumor therapies: complex links.
    Belgiovine C; D'Incalci M; Allavena P; Frapolli R
    Cell Mol Life Sci; 2016 Jul; 73(13):2411-24. PubMed ID: 26956893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.